Complete Remission with Incomplete Count Recovery (CRi) Prior to Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukaemia is Associated with a High Non-relapse Mortality without Increased Relapse Risk

被引:0
|
作者
Innes, A. [1 ]
Woolley, P. [2 ]
Szydlo, R. [1 ]
Lozano, S. [2 ]
Fernando, F. [2 ]
Bansal, D. [2 ]
Palanicawandar, R. [2 ]
Milojkovic, D. [2 ]
May, P. [1 ]
Nadal-Melsio, E. [2 ]
Yebra-Fernandez, E. [2 ]
Olavarria, E. [2 ]
Apperley, J. [1 ]
Pavlu, J. [2 ]
机构
[1] Imperial Coll London, Ctr Haematol, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Haematol, London, England
关键词
acute myeloid leukaemia; transplant;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH19-PO-1
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [41] The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
    Kim, Dennis D. H.
    Basso, Igor Novitzky
    Kim, Taehyung Simon
    Yi, Seong Yoon
    Kim, Kyoung Ha
    Murphy, Tracy
    Chan, Steven
    Minden, Mark
    Pasic, Ivan
    Lam, Wilson
    Law, Arjun
    Michelis, Fotios V.
    Gerbitz, Armin
    Viswabandya, Auro
    Lipton, Jeffrey
    Kumar, Rajat
    Ng, Stanley W. K.
    Stockley, Tracy
    Zhang, Tong
    King, Ian
    Mattsson, Jonas
    Wang, Jean C. Y.
    EJHAEM, 2022, 3 (03): : 873 - 884
  • [42] KIR-ligand disparities are associated with a decreased risk of relapse after allogeneic stem cell transplantation for myeloid leukaemia
    Beelen, DW
    Ottinger, H
    Ferencik, S
    Elmaagacli, AH
    Peceny, R
    Grosse-Wilde, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S17 - S17
  • [43] Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality
    S Fuji
    T Mori
    N Khattry
    J Cheng
    Y R Do
    K Yakushijin
    S Kohashi
    T Fukuda
    S-W Kim
    Bone Marrow Transplantation, 2015, 50 : 100 - 105
  • [44] Impact of minimal residual disease in adult patients with acute myeloid leukaemia in complete remission undergoing allogeneic haematopoietic stem cell transplantation
    Grubovic, R. M.
    Schiller, G. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S382 - S383
  • [45] Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality
    Fuji, S.
    Mori, T.
    Khattry, N.
    Cheng, J.
    Do, Y. R.
    Yakushijin, K.
    Kohashi, S.
    Fukuda, T.
    Kim, S-W
    BONE MARROW TRANSPLANTATION, 2015, 50 (01) : 100 - 105
  • [46] Immediate allogeneic haematopoietic cell transplantation during induction chemotherapy in high-risk acute myeloid leukaemia
    Platzbecker, U
    Thiede, C
    Illmer, T
    Schaich, M
    Schäkel, U
    Schuler, U
    Neubauer, A
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S33 - S33
  • [47] Allogeneic haematopoietic stem cell transplantation after first relapse of acute myeloid leukaemia: a retrospective analysis on behalf of the Northern Italy Leukaemia Group (NILG) experience
    Cavattoni, I.
    Morello, E.
    Casini, M.
    Intermesoli, T.
    Oldani, E.
    Borlenghi, E.
    Rossi, G.
    Minotto, C.
    Terruzzi, E.
    Pogliani, E.
    Audisio, E.
    Marmont, F.
    Rambaldi, A.
    Bassan, R.
    Cortelazzo, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S63 - S63
  • [48] Relapse of acute leukaemia or myelodysplastic syndrome after an allogeneic stem cell transplantation: increased risk for invasive mould infections
    Nihtinen, A.
    Volin, L.
    Anttila, V. -J.
    Juvonen, E.
    Ruutu, T.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S176 - S177
  • [49] Siremadlin Monotherapy and in Combination with Donor Lymphocyte Infusion for Patients with Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation Who Are in Complete Remission but at High Risk for Relapse
    Zeiser, Robert
    Schmid, Christoph
    Alatrash, Gheath
    Ram, Ron
    Wu, Yuan
    Weber, Hans-Jochen Jochen
    Grzesiak, Stephanie
    Eldjerou, Lamis K.
    Craddock, Charles
    BLOOD, 2022, 140 : 8944 - 8945
  • [50] SEROLOGICAL EVIDENCE OF HEPATITIS C IS ASSOCIATED WITH WORSE NON-RELAPSE MORTALITY AND OVERALL SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Ramos, C. A.
    Saliba, R. M.
    Khorshid, O.
    de Padua, L.
    Giralt, S.
    Andersson, B. S.
    Ueno, N. T.
    Shpall, E. J.
    Hosing, C.
    Qureshi, S. R.
    Champlin, R. E.
    de Lima, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 103 - 104